|
|
| | D-myo-Inositol, 1-(2R)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 3-(dihydrogen phosphate) Basic information |
| Product Name: | D-myo-Inositol, 1-(2R)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 3-(dihydrogen phosphate) | | Synonyms: | D-myo-Inositol, 1-(2R)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 3-(dihydrogen phosphate);(Phosphonooxy)cyclohexyl]oxy]phosphinyl]oxy]-1-[[(1-oxohexadecyl)oxy]methyl]ethyl ester;(R)-2-Hexadecanoyloxy-3-[hydroxy-((1S,2R,3R,4S,5S,6R)-2,4,5,6-tetrahydroxy-3-;Cmc_6572;Cmc_9578;Dipalmitoylphosphoinositol;D-Myo-inositol, 1-[(2R)-2,3-bis[(1-oxohexadecyl)oxy]propyl hydrogen phosphate] 3-(dihydrogen phosphate) (9ci);D-Myo-phosphatidylinositol 3-phosphate (ptdins(3)p) | | CAS: | 165689-81-6 | | MF: | C41H80O16P2 | | MW: | 891.01 | | EINECS: | | | Product Categories: | SiChem | | Mol File: | 165689-81-6.mol |  |
| | D-myo-Inositol, 1-(2R)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 3-(dihydrogen phosphate) Chemical Properties |
| Boiling point | 921.1±75.0 °C(Predicted) | | density | 1.21±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | DMSO: soluble
chloroform: soluble
ethanol: soluble | | pka | 1.43±0.50(Predicted) | | InChIKey | SZPQTEWIRPXBTC-KFOWTEFUSA-N | | SMILES | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | D-myo-Inositol, 1-(2R)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 3-(dihydrogen phosphate) Usage And Synthesis |
| Uses | PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium) is deuterium labeled PtdIns(3)P[1]. | | Definition | ChEBI: 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'D-myo-inositol-3'-phosphate) is a 1-phosphatidyl-1D-myo-inositol 3-phosphate in which both phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl). It is a 1-phosphatidyl-1D-myo-inositol 3-phosphate and a 1,2-dipalmitoylglycero-3-phospho-(1'-D-myo-inositol-3'-phosphate). It is functionally related to a hexadecanoic acid. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:10.1177/1060028018797110 |
| | D-myo-Inositol, 1-(2R)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 3-(dihydrogen phosphate) Preparation Products And Raw materials |
|